miltefosine March 20, 2017 miltefosine Trade Name Impavido Orphan Indication Primary amebic encephalitis (PAM) USA Market Approval USA USA Designation Date 2016-12-06 00:00:00 Sponsor Profounda, Inc.;5790 Hoffner Avenue, Suite 507;Orlando, Florida, 32822
